JP2006505530A5 - - Google Patents

Download PDF

Info

Publication number
JP2006505530A5
JP2006505530A5 JP2004532517A JP2004532517A JP2006505530A5 JP 2006505530 A5 JP2006505530 A5 JP 2006505530A5 JP 2004532517 A JP2004532517 A JP 2004532517A JP 2004532517 A JP2004532517 A JP 2004532517A JP 2006505530 A5 JP2006505530 A5 JP 2006505530A5
Authority
JP
Japan
Prior art keywords
azabicyclo
oct
carboxamide
octane
thiophene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP2004532517A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006505530A (ja
Filing date
Publication date
Priority claimed from SE0202598A external-priority patent/SE0202598D0/xx
Application filed filed Critical
Publication of JP2006505530A publication Critical patent/JP2006505530A/ja
Publication of JP2006505530A5 publication Critical patent/JP2006505530A5/ja
Abandoned legal-status Critical Current

Links

JP2004532517A 2002-09-02 2003-09-01 アルファ−7ニコチン受容体作用剤およびスタチンの組み合わせ Abandoned JP2006505530A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0202598A SE0202598D0 (sv) 2002-09-02 2002-09-02 Alpha-7 Nicotinic receptor agonists and statins in combination
PCT/SE2003/001352 WO2004019947A1 (en) 2002-09-02 2003-09-01 Alpha-7 nicotinic receptor agonists and statins in combination

Publications (2)

Publication Number Publication Date
JP2006505530A JP2006505530A (ja) 2006-02-16
JP2006505530A5 true JP2006505530A5 (cg-RX-API-DMAC7.html) 2006-10-19

Family

ID=20288874

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004532517A Abandoned JP2006505530A (ja) 2002-09-02 2003-09-01 アルファ−7ニコチン受容体作用剤およびスタチンの組み合わせ

Country Status (12)

Country Link
US (2) US20050256146A1 (cg-RX-API-DMAC7.html)
EP (1) EP1545537B9 (cg-RX-API-DMAC7.html)
JP (1) JP2006505530A (cg-RX-API-DMAC7.html)
AT (1) ATE358485T1 (cg-RX-API-DMAC7.html)
AU (1) AU2003256203A1 (cg-RX-API-DMAC7.html)
DE (1) DE60313004T2 (cg-RX-API-DMAC7.html)
DK (1) DK1545537T3 (cg-RX-API-DMAC7.html)
ES (1) ES2283860T3 (cg-RX-API-DMAC7.html)
PT (1) PT1545537E (cg-RX-API-DMAC7.html)
SE (1) SE0202598D0 (cg-RX-API-DMAC7.html)
SI (1) SI1545537T1 (cg-RX-API-DMAC7.html)
WO (1) WO2004019947A1 (cg-RX-API-DMAC7.html)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10164139A1 (de) 2001-12-27 2003-07-10 Bayer Ag 2-Heteroarylcarbonsäureamide
WO2009017454A1 (en) * 2007-07-30 2009-02-05 Astrazeneca Ab New therapeutic combination of a gsk3 inhibitor and an a7-nicotinic agonist 960
CA2728675A1 (en) 2008-06-20 2009-12-23 Astrazeneca Ab Dibenzothiazepine derivatives and use thereof
FR2958850B1 (fr) * 2010-04-14 2012-07-06 Centre Nat Rech Scient Medicaments pour la prevention ou le traitement des addictions aux drogues
TWI519532B (zh) 2010-05-17 2016-02-01 艾維沃製藥公司 (R)-7-氯-N-(啶-3-基)苯並[b]噻吩-2-羧醯胺鹽酸鹽單水合物之結晶形體
EP2593447B1 (de) 2010-07-15 2016-08-17 Bayer Intellectual Property GmbH 3-pyridyl-heteroarylcarboxamidverbindungen als schädlingsbekämpfungsmittel
LT2685986T (lt) * 2011-03-18 2020-03-10 Genzyme Corporation Gliukozilceramido sintazės slopiklis
GB201111705D0 (en) 2011-07-07 2011-08-24 Takeda Pharmaceutical Compounds and their use
GB201111704D0 (en) 2011-07-07 2011-08-24 Takeda Pharmaceutical Novel compounds
JO3115B1 (ar) 2011-08-22 2017-09-20 Takeda Pharmaceuticals Co مركبات بيريدازينون واستخدامها كمثبطات daao
JPWO2013161871A1 (ja) * 2012-04-25 2015-12-24 興和株式会社 Tlr阻害作用を有するチオフェン誘導体
RU2017136693A (ru) 2012-05-08 2019-02-08 Форум Фармасьютикалз, Инк. Способы поддержания, лечения или улучшения когнитивной функции
GB201209587D0 (en) 2012-05-30 2012-07-11 Takeda Pharmaceutical Therapeutic compounds
US9593106B2 (en) 2013-02-07 2017-03-14 Heptares Therapeutics Limited Piperidin-1-yl and azepin-1-yl carboxylates as muscarinic M4 receptor agonists
JP6401254B2 (ja) 2013-06-21 2018-10-10 武田薬品工業株式会社 プロキネシチン受容体のモジュレータとしての1−スルホニルピペリジン誘導体
GB201314286D0 (en) 2013-08-08 2013-09-25 Takeda Pharmaceutical Therapeutic Compounds
GB201318222D0 (en) 2013-10-15 2013-11-27 Takeda Pharmaceutical Novel compounds
GB201320905D0 (en) 2013-11-27 2014-01-08 Takeda Pharmaceutical Therapeutic compounds
TW201613864A (en) 2014-02-20 2016-04-16 Takeda Pharmaceutical Novel compounds
CN103923105B (zh) * 2014-04-17 2016-08-24 北京大学 2-中氮茚甲酰胺类化合物及其制备和用途
GB201616839D0 (en) 2016-10-04 2016-11-16 Takeda Pharmaceutical Company Limited Therapeutic compounds
GB201619514D0 (en) 2016-11-18 2017-01-04 Takeda Pharmaceuticals Co Novel compounds
EP3806956A4 (en) * 2018-06-13 2022-08-10 Zachriel Neurosciences, Llc METHODS AND DOSAGE REGIMES FOR PREVENTING OR DELAYING THE ONSET OF ALZHEIMER'S DISEASE AND OTHER FORMS OF DEMENTIA AND MILD COGNITIVE IMPAIRMENT
JP2021138648A (ja) 2020-03-04 2021-09-16 武田薬品工業株式会社 経口固形製剤
GB202414197D0 (en) 2024-09-27 2024-11-13 Addex Pharmaceuticals Sa Novel compounds
GB202414193D0 (en) 2024-09-27 2024-11-13 Addex Pharmaceuticals Sa Novel compounds

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3708962B2 (ja) * 1994-08-24 2005-10-19 アストラゼネカ・アクチエボラーグ 治療に有用なスピロ−アザ二環式化合物
AR013184A1 (es) * 1997-07-18 2000-12-13 Astrazeneca Ab Aminas heterociclicas espiroazobiciclicas, composicion farmaceutica, uso de dichas aminas para preparar medicamentos y metodo de tratamiento o profilaxis
SE9900100D0 (sv) * 1999-01-15 1999-01-15 Astra Ab New compounds
SE9903996D0 (sv) * 1999-11-03 1999-11-03 Astra Ab New compounds
WO2002017358A2 (en) * 2000-08-21 2002-02-28 Pharmacia & Upjohn Company Quinuclidine-substituted heteroaryl moieties for treatment of disease (nicotinic acetylcholine receptor antagonists)
US6569865B2 (en) * 2001-06-01 2003-05-27 Astrazeneca Ab Spiro 1-azabicyclo[2.2.2]octane-3,2′(3′h)-furo[2,3-b]pyridine
US20050222122A1 (en) * 2002-04-02 2005-10-06 Sean Lilienfeld Statin therapy for enhancing cognitive maintenance
AU2003279492A1 (en) * 2002-12-11 2004-06-30 Pharmacia & Upjohn Company Llc Treatment of diseases with combinations of alpha 7 nicotinic acetylcholine receptor agonists and other compounds
WO2005092890A2 (en) * 2004-03-25 2005-10-06 Memory Pharmaceuticals Corporation Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and uses thereof

Similar Documents

Publication Publication Date Title
US20090192180A1 (en) Alpha-7 Nicotinic Receptor Agonists and Statins In Combination
RU2002118302A (ru) Новые биарилкарбоксамиды
JP2003503504A5 (cg-RX-API-DMAC7.html)
JP2003514818A5 (cg-RX-API-DMAC7.html)
JP2006528685A5 (cg-RX-API-DMAC7.html)
JP2002523502A5 (cg-RX-API-DMAC7.html)
RU2008148902A (ru) Производные имидазол-пиримидина для лечения заболеваний, связанных с киназой гликогенсинтазы 3 (gsk3)
HRP20130007T1 (hr) Lijeäśenje kognitivnih poremeä†aja pomoä†u (r)-7-kloro-n-(kinuklidin-3-il)benzo[b]tiofen-2-karboksamida i njegovih farmaceutski prihvatljivih soli
HRP20171793T1 (hr) Farmaceutske formulacije koje sadrže kristalne oblike (r)-7-kloro-n-(kinuklidin-3-il)benzo(b)tiofen-2-karboksamid hidroklorid monohidrata
AU2007271186B2 (en) Combination of HMG-CoA reductase inhibitors with phosphodiesterase 4 inhibitors for the treatment of inflammatory pulmonary diseases
JP2008526861A5 (cg-RX-API-DMAC7.html)
JP2014503568A (ja) ニコチン酸アセチルコリン受容体α7活性化因子の使用
JP2009514802A5 (cg-RX-API-DMAC7.html)
FI3707143T3 (fi) Uusia analogeja androgeenireseptorin ja glukokortikoidireseptorin modulaattoreina
CN105263492B (zh) α7烟碱型乙酰胆碱受体激动剂在治疗发作性睡病中的应用
RU2007134414A (ru) Бензоксазолкарбоксамиды для лечения индуцированной химиотерапией тошноты и рвоты (cini) и синдрома раздраженного кишечника с преобладанием диареи (ibs-d)
JP2002542281A5 (cg-RX-API-DMAC7.html)
RU2007126638A (ru) Профилактическое или терапевтическое средство для лечения расстройства сна
JP2007524699A5 (cg-RX-API-DMAC7.html)
JP2003055360A5 (cg-RX-API-DMAC7.html)
AU2012232711B2 (en) Combinations of alpha 7 nicotinic acetylcholine receptor activators and mGluR5 antagonists for use in dopamine induced dyskinesia in Parkinson's Disease
JP2005510482A5 (ja) 線維筋痛症候群の治療用医薬
JP2020193188A (ja) 慢性副鼻腔炎の予防剤または治療剤、およびこれらを製造するためのスタチンの使用
ZA200407896B (en) New combination of reversible proton pump inhibitors and airway therapeutics for treating airway disorders
HK1077193B (en) Alpha-7 nicotinic receptor agonists and statins in combination